These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6647995)

  • 21. Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice.
    Thallinger C; Werzowa J; Poeppl W; Kovar FM; Pratscher B; Valent P; Quehenberger P; Joukhadar C
    J Invest Dermatol; 2007 Oct; 127(10):2411-7. PubMed ID: 17508024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.
    Busch C; Geisler J; Lillehaug JR; Lønning PE
    Eur J Cancer; 2010 Jul; 46(11):2127-33. PubMed ID: 20541396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicity and complications of vascular isolation and hyperthermic perfusion with imidazole carboxamide (DTIC) in melanoma.
    Didolkar MS; Fitzpatrick JL; Jackson AJ; Johnston GS
    Cancer; 1986 May; 57(10):1961-6. PubMed ID: 3955502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma.
    Lee SM; Margison GP; Woodcock AA; Thatcher N
    Br J Cancer; 1993 Jun; 67(6):1356-60. PubMed ID: 8512821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
    Rudolf Z; Strojan P
    Neoplasma; 1996; 43(2):93-7. PubMed ID: 8843969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
    Thatcher D; Lind M; Morgenstern G; Carr T; Chadwick G; Jones R; Craig P
    Cancer; 1989 Apr; 63(7):1296-302. PubMed ID: 2646005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH; Atzpodien J; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prolonged external carotid artery infusion of small doses of anticancerous drugs in treatment of head and neck carcinoma---observation of late curative effects of 101 cases (author's transl)].
    Zhang LY
    Zhonghua Kou Qiang Ke Za Zhi; 1981 Jun; 16(2):121-3. PubMed ID: 6949709
    [No Abstract]   [Full Text] [Related]  

  • 29. DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors.
    Altimari AF; Badrinath K; Reisel HJ; Prinz RA
    Surgery; 1987 Dec; 102(6):1009-17. PubMed ID: 2825370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dacarbazine (DTIC) in malignant melanoma: reduced toxicity with protection from light.
    Koriech OM; Shükla VS
    Clin Radiol; 1981 Jan; 32(1):53-5. PubMed ID: 7214822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
    Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
    Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.
    Adkins DR; Salzman D; Boldt D; Kuhn J; Irvin R; Roodman GD; Lyons R; Smith L; Freytes CO; LeMaistre CF
    J Clin Oncol; 1994 Sep; 12(9):1890-901. PubMed ID: 7916039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [DTIC in the therapy of solid tumours (author's transl)].
    Kokron O; Pridun N; Zischinsky W
    Wien Klin Wochenschr; 1978 Dec; 90(24):864-7. PubMed ID: 741753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermochemotherapy for melanoma metastases in liver.
    Storm FK; Kaiser LR; Goodnight JE; Harrison WH; Elliott RS; Gomes AS; Morton DL
    Cancer; 1982 Mar; 49(6):1243-8. PubMed ID: 7059946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.
    Bellett RE; Mastrangelo MJ; Laucius JF; Bodurtha AJ
    Cancer Treat Rep; 1976 May; 60(5):595-600. PubMed ID: 791478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients.
    Chabot GG; Flaherty LE; Valdivieso M; Baker LH
    Cancer Chemother Pharmacol; 1990; 27(2):157-60. PubMed ID: 2249333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Budd-Chiari syndrome following dacarbazine therapy of malignant melanoma--an avoidable complication?].
    Leyh F; Winzer M; Weber M; Hypa F
    Z Hautkr; 1985 Jun; 60(12):961-72. PubMed ID: 4024678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma.
    Costanza ME; Nathanson L; Costello WG; Wolter J; Brunk SF; Colsky J; Hall T; Oberfield RA; Regelson W
    Cancer; 1976 Apr; 37(4):1654-9. PubMed ID: 769936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of metastatic malignant melanoma localized to an extremity].
    Jacobsen KD; Tausjø J; Hager B; Gundersen S
    Tidsskr Nor Laegeforen; 2010 Jan; 130(1):21-4. PubMed ID: 20094118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.
    Weber JS; Zarour H; Redman B; Trefzer U; O'Day S; van den Eertwegh AJ; Marshall E; Wagner S
    Cancer; 2009 Sep; 115(17):3944-54. PubMed ID: 19536884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.